Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

BPA

Biosante Pharma (BPA)

Biosante Pharmaceuticals
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:BPA
日付受信時刻ニュースソース見出しコード企業名
2007/11/0106 : 21Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Amended Securities Registration (section 12(b)) (8-A12B/A)AMEX:BPABiosante Pharmaceuticals
2007/10/2500 : 23Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filing (8-K)AMEX:BPABiosante Pharmaceuticals
2007/10/2500 : 23Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filingAMEX:BPABiosante Pharmaceuticals
2007/10/2500 : 23Edgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filingAMEX:BPABiosante Pharmaceuticals
2007/09/2502 : 57PR Newswire (US)WallSt.net Announces Upcoming Interview with CEO of BioSante PharmaceuticalsAMEX:BPABiosante Pharmaceuticals
2007/08/1505 : 15Business WireBioSante Pharmaceuticals Reports Second Quarter 2007 Financial ResultsAMEX:BPABiosante Pharmaceuticals
2007/08/0821 : 00Business WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
2007/07/2521 : 00Business WireBioSante Pharmaceuticals Announces Positive Results for its CaP Technology for Use in Aesthetic MedicineAMEX:BPABiosante Pharmaceuticals
2007/07/1121 : 00Business WireBioSante Pharmaceuticals Announces New Findings for Potential Bird Flu VaccineAMEX:BPABiosante Pharmaceuticals
2007/07/1020 : 00PR Newswire (US)WallSt.net (www.wallst.net ) Updates the Investment Community Through All-New Interviews with BPA, PPCO and NVAXAMEX:BPABiosante Pharmaceuticals
2007/06/2820 : 00Business WireBioSante Pharmaceuticals, Inc. Joins Russell Microcap IndexAMEX:BPABiosante Pharmaceuticals
2007/06/1921 : 00Business WireBioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study InitiationAMEX:BPABiosante Pharmaceuticals
2007/06/1421 : 00Business WireBioSante Pharmaceuticals Completes $18.3 Million Private Placement of Common StockAMEX:BPABiosante Pharmaceuticals
2007/06/1321 : 45PR Newswire (US)Bradley Pharmaceuticals Announces Launch of Elestrin(TM)AMEX:BPABiosante Pharmaceuticals
2007/05/3022 : 12Business WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
2007/05/2522 : 26Business WireBioSante Pharmaceuticals Announces $16.5 Million Private Placement of Common StockAMEX:BPABiosante Pharmaceuticals
2007/05/1621 : 00Business WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
2007/05/0721 : 00Business WireBioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei BioscienceAMEX:BPABiosante Pharmaceuticals
2007/05/0421 : 45PR Newswire (US)Bradley Pharmaceuticals to Preview New Products at ACOG MeetingAMEX:BPABiosante Pharmaceuticals
2007/05/0220 : 45Business WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
2007/05/0206 : 00Business WireBioSante Pharmaceuticals Reports First Quarter 2007 Financial ResultsAMEX:BPABiosante Pharmaceuticals
2007/04/1121 : 45PR Newswire (US)Bradley Pharmaceuticals' Elestrin(TM) Receives New Patent to 2022AMEX:BPABiosante Pharmaceuticals
2007/04/1021 : 00Business WireBioSante Pharmaceuticals Announces Issuance of New Patent Covering Elestrin(TM) and LibiGel(R)AMEX:BPABiosante Pharmaceuticals
2007/04/0303 : 09PR Newswire (US)Dawson James Securities Reiterates Strong Buy Recommendation on Antares Pharma (Amex: AIS) with $4.00 Price TargetAMEX:BPABiosante Pharmaceuticals
2007/03/2620 : 30Business WireBioSante Pharmaceuticals Receives Milestone Payment from Bradley PharmaceuticalsAMEX:BPABiosante Pharmaceuticals
2007/03/0906 : 34Business WireBioSante Pharmaceuticals Reports Net Profit of $2.8 million for 2006 And Investor Conference CallAMEX:BPABiosante Pharmaceuticals
2007/03/0822 : 00Business WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
2007/01/3022 : 00Business WireBioSante Pharmaceuticals Announces Positive Bird Flu Results Using Proprietary Vaccine Adjuvant in Pre-Clinical StudyAMEX:BPABiosante Pharmaceuticals
2007/01/1623 : 00Business WireStephen M. Simes, President and CEO of BioSante Pharmaceuticals, Inc., Talks to The Wall Street TranscriptAMEX:BPABiosante Pharmaceuticals
2006/12/1921 : 45PR Newswire (US)Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)AMEX:BPABiosante Pharmaceuticals
 Showing the most relevant articles for your search:AMEX:BPA

最近閲覧した銘柄

Delayed Upgrade Clock